Andere talen Biofrontera Inc.

Aandelen

BFRI

US09077D2099

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 02-07-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,84 ^USD	-5,83%		-6,73%	-69,68%

24/06	Biofrontera kondigt de lancering aan van een nieuwe, FDA-goedgekeurde roodlichtbron, de RhodoLED® XL Lamp	CI
16/05	Transcript : Biofrontera Inc., Q1 2024 Earnings Call, May 16, 2024

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Biofrontera Announces the Launch of a New, FDA-Approved Red Light Source, the RhodoLED® XL Lamp	24/06
Biofrontera Announces the Launch of A New, FDA-Approved Red Light Source, the RhodoLED® XL Lamp	24/06
Earnings Flash (BFRI) BIOFRONTERA Reports Q1 Revenue $7.9M, vs. Street Est of $10.9M	15/05
Biofrontera Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05
Biofrontera : Certificate of Incorporation/Bylaws - Form 8-K	02/05
Biofrontera Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	15/03
Biofrontera Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	15/03
Biofrontera Files Prospectus for Potential Secondary Stock Offerings	11/03
Medicus Pharma Names COO	05/03
Biofrontera Inc. announced that it has received $8 million in funding	22/02
BIOFRONTERA AG ANNOUNCES REVISED STRATEGY	21/02
BIOFRONTERA AG, BIOFRONTERA TRANSFERS CLINICAL RESEARCH TO THE U.S.	21/02
Biofrontera Inc. Announces Restructuring of Supply Agreement with Biofrontera Ag	20/02
Biofrontera Inc. announced that it expects to receive $8 million in funding	19/02
MORNING BRIEFING - Deutschland/Europa -2-	16/02
Biofrontera Inc. Announces FDA Filing of Supplemental New Drug Application for Ameluz(R) to Permit Up to Three Tubes Per Use	05/02
Certain Warrants of Biofrontera Inc. are subject to a Lock-Up Agreement Ending on 1-FEB-2024.	01/02
Certain Common Stock of Biofrontera Inc. are subject to a Lock-Up Agreement Ending on 1-FEB-2024.	01/02
Certain Stock options of Biofrontera Inc. are subject to a Lock-Up Agreement Ending on 1-FEB-2024.	01/02
Biofrontera Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year Ended December 31, 2023	11/01

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Biofrontera Inc.

Aandelen

BFRI

US09077D2099

Andere talen

Filters